{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:12:32Z","timestamp":1760008352094,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.det.2022.07.020","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T07:03:02Z","timestamp":1666940582000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preventative Options and the Future of Chemoprevention for Cutaneous Tumors"],"prefix":"10.1016","volume":"41","author":[{"given":"Jane Margaret","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Moy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Moy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.det.2022.07.020_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.det.2022.07.020_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0033-1353377","article-title":"Chemoprevention of nonmelanoma skin cancer","volume":"29","author":"Soltani-Arabshahi","year":"2013","journal-title":"Facial Plast Surg"},{"issue":"11","key":"10.1016\/j.det.2022.07.020_bib3","first-page":"1566","article-title":"Nonmelanoma skin cancer chemoprevention","volume":"37","author":"Prado","year":"2011","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg [et\u00a0al]"},{"issue":"16","key":"10.1016\/j.det.2022.07.020_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"9180","key":"10.1016\/j.det.2022.07.020_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.det.2022.07.020_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1684\/ejd.2018.3251","article-title":"Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis","volume":"28","author":"Silva","year":"2018","journal-title":"Eur J Dermatol"},{"issue":"3S","key":"10.1016\/j.det.2022.07.020_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2021.12.019","article-title":"Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel","volume":"86","author":"Rigel","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2022.07.020_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/acs.chemrestox.0c00461","article-title":"Benzophenone Accumulates over Time from the Degradation of Octocrylene in Commercial Sunscreen Products","volume":"34","author":"Downs","year":"2021","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.det.2022.07.020_bib9","unstructured":"Light D, Kucera K, Wu Q. Valisure Citizen Petition on Benzene in sunscreen and after-Sun care products.; 2021."},{"key":"10.1016\/j.det.2022.07.020_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/CCID.S220741","article-title":"Six critical questions for DNA repair enzymes in skincare products: a review in dialog","volume":"12","author":"Yarosh","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"10.1016\/j.det.2022.07.020_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14712598.8.6.829","article-title":"T4 endonuclease V: review and application to dermatology","volume":"8","author":"Cafardi","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.sder.2011.01.003","article-title":"New agents for prevention of ultraviolet-induced nonmelanoma skin cancer","volume":"30","author":"Camp","year":"2011","journal-title":"Semin Cutan Med Surg"},{"issue":"Suppl 1","key":"10.1016\/j.det.2022.07.020_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/exd.13819","article-title":"Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety","volume":"28","author":"Snaidr","year":"2019","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.det.2022.07.020_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jid.5701058","article-title":"UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2022.07.020_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaad.2010.05.042","article-title":"Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study","volume":"65","author":"Torti","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1568009043481632","article-title":"NSAIDs and chemoprevention","volume":"4","author":"Rao","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.29357","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer","volume":"137","author":"Reinau","year":"2015","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.det.2022.07.020_bib18","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/jid.2014.192","article-title":"Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention","volume":"134","author":"Elmets","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"24","key":"10.1016\/j.det.2022.07.020_bib19","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1568009618666180430125201","article-title":"Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases","volume":"19","author":"Qui\u00f1ones","year":"2019","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.det.2022.07.020_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.taap.2012.12.009","article-title":"Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis","volume":"268","author":"Chaudhary","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.det.2022.07.020_bib22","first-page":"562","article-title":"Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects","volume":"32","author":"Otley","year":"2006","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg [et\u00a0al]"},{"issue":"2","key":"10.1016\/j.det.2022.07.020_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.14852","article-title":"Current perspective on actinic keratosis: a review","volume":"177","author":"Siegel","year":"2017","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2022.07.020_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2022.07.020_bib25","series-title":"Habif\u2019s clinical Dermatology","first-page":"815","article-title":"Premalignant and malignant nonmelanoma skin tumors","author":"Dinulos","year":"2021"},{"issue":"23","key":"10.1016\/j.det.2022.07.020_bib26","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.det.2022.07.020_bib27","first-page":"1281","article-title":"Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine","volume":"9","author":"Alberts","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev A Publ Am Assoc Cancer Res Cosponsored By Am Soc Prev Oncol"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1940-6207.CAPR-09-0096","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer","volume":"3","author":"Bailey","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"10.1016\/j.det.2022.07.020_bib29","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1940-6207.CAPR-12-0233","article-title":"A\u00a0phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity","volume":"5","author":"Kreul","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.det.2022.07.020_bib30","first-page":"945","article-title":"Development of difluoromethylornithine (DFMO) as a chemoprevention agent","volume":"5","author":"Meyskens","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.det.2022.07.020_bib31","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.2147\/CMAR.S200059","article-title":"The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances","volume":"11","author":"Saraei","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2021.02.042","article-title":"Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland","volume":"85","author":"Adalsteinsson","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2022.07.020_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1940-6207.CAPR-20-0376","article-title":"Risk of Skin Cancer Associated with Metformin Use: A Meta-Analysis of Randomized Controlled Trials and Observational Studies","volume":"14","author":"Chang","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.det.2022.07.020_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaad.2017.12.016","article-title":"Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes","volume":"78","author":"Tseng","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2022.07.020_bib35","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1111\/ijd.14829","article-title":"The effect of metformin on the risk of recurrent nonmelanoma skin cancers","volume":"59","author":"Ravishankar","year":"2020","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2022.07.020_bib36","first-page":"3864","article-title":"Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA","volume":"6","author":"Katiyar","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.det.2022.07.020_bib37","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/jid.2008.354","article-title":"Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation","volume":"129","author":"Meeran","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2022.07.020_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijwd.2017.10.002","article-title":"Skin cancer knowledge, attitudes, beliefs, and prevention practices among medical students: A systematic search and literature review","volume":"4","author":"Nahar","year":"2018","journal-title":"Int J Women\u2019s Dermatology"},{"issue":"7","key":"10.1016\/j.det.2022.07.020_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/DSS.0000000000002909","article-title":"Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons","volume":"47","author":"Arzeno","year":"2021","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.det.2022.07.020_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.det.2019.05.010","article-title":"Skin Cancer Detection Technology","volume":"37","author":"Dorrell","year":"2019","journal-title":"Dermatol Clin"},{"issue":"8","key":"10.1016\/j.det.2022.07.020_bib41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ajhp\/zxab094","article-title":"Tirbanibulin","volume":"78","year":"2021","journal-title":"Am J Health Pharm"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863522000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863522000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:46:54Z","timestamp":1760006814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863522000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0733863522000729"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2022.07.020","relation":{},"ISSN":["0733-8635"],"issn-type":[{"type":"print","value":"0733-8635"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventative Options and the Future of Chemoprevention for Cutaneous Tumors","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2022.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}